MedPath

Keratex

Approved
Approval ID

d19063d2-0fec-43d3-93b2-cffbb361ab4d

Product Type

OTC ANIMAL DRUG LABEL

Effective Date

May 7, 2025

Manufacturers
FDA

Penleigh Irving Ltd

DUNS: 505992479

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

microcrystalline wax, rosin, turpentine and sulfur

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code27426-070
Product Classification
G
Generic Name
microcrystalline wax, rosin, turpentine and sulfur
Product Specifications
Route of AdministrationTopical
Effective DateMay 7, 2025
FDA Product Classification

INGREDIENTS (4)

MICROCRYSTALLINE WAXActive
Quantity: 103.31 g in 147 g
Code: XOF597Q3KY
Classification: ACTIB
ROSINActive
Quantity: 35.11 g in 147 g
Code: 88S87KL877
Classification: ACTIB
TURPENTINEActive
Quantity: 7.11 g in 147 g
Code: XJ6RUH0O4G
Classification: ACTIB
SULFURActive
Quantity: 1.44 g in 147 g
Code: 70FD1KFU70
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Keratex - FDA Drug Approval Details